On the basis of these outcomes, we speculated that PCDHGA9 potentially reduces the invasion and metastasis of CRC by facilitating the degradation of β-catenin, thereby leading to a reduction in β-catenin protein present in CRC cells. The gene discussed is PCDHGA9; the disease is colorectal carcinoma.